XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.1
Identifiable Intangible Assets
 3 Months Ended
Apr. 03, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Identifiable Intangible Assets Identifiable Intangible Assets
A. Identifiable Intangible Assets
The following summarizes the components of Identifiable intangible assets:
April 3, 2022December 31, 2021
(MILLIONS)Gross
Carrying
Amount		Accumulated
Amortization		Identifiable
Intangible
Assets, less
Accumulated
Amortization		Gross
Carrying
Amount		Accumulated
Amortization		Identifiable
Intangible
Assets, less
Accumulated
Amortization
Finite-lived intangible assets
Developed technology rights$73,212 $(54,397)$18,815 $73,346 $(53,732)$19,614 
Brands922 (816)106 922 (807)115 
Licensing agreements and other2,302 (1,329)973 2,284 (1,299)985 
76,436 (56,542)19,894 76,552 (55,838)20,714 
Indefinite-lived intangible assets
Brands827 827 827 827 
IPR&D(a)
8,122 8,122 3,092 3,092 
Licensing agreements and other(a)
973 973 513 513 
9,922 9,922 4,432 4,432 
Identifiable intangible assets(a), (b)
$86,358 $(56,542)$29,816 $80,984 $(55,838)$25,146 
(a)The increase in the gross carrying amounts mainly reflect the impact of the acquisition of Arena. See Note 2A.
(b)The increase is primarily due to the acquisition of Arena, partially offset by amortization expense.
B. Goodwill
The following summarizes the changes in the carrying amount of Goodwill:
(MILLIONS)
Total(a)
Balance, January 1, 2022
$49,208 
Additions(b)
1,023 
Other(c)
(21)
Balance, April 3, 2022
$50,211 
(a)All goodwill is assigned within the Biopharma reportable segment.
(b)Additions relate to our acquisition of Arena. See Note 2A.
(c)Other represents the impact of foreign exchange.